相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer
Xi Cheng et al.
CANCER LETTERS (2018)
A phase II study of apatinib in patients with recurrent epithelial ovarian cancer
Mingming Miao et al.
GYNECOLOGIC ONCOLOGY (2018)
Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target
Gustav van Niekerk et al.
CELLULAR ONCOLOGY (2018)
Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study
Chun-Yan Lan et al.
LANCET ONCOLOGY (2018)
Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression
Jieping Hu et al.
BRITISH JOURNAL OF CANCER (2018)
Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer
Khalid El Bairi et al.
CELLULAR ONCOLOGY (2017)
Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer
Anna Markowska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Successful treatment of ovarian cancer with apatinib combined with chemotherapy: A case report
Mingzi Zhang et al.
MEDICINE (2017)
Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report
Linghui Deng et al.
ONCOTARGETS AND THERAPY (2017)
Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma
Kuisheng Liu et al.
CELL DEATH & DISEASE (2017)
Sox5 regulates beta-cell phenotype and is reduced in type 2 diabetes
A. S. Axelsson et al.
NATURE COMMUNICATIONS (2017)
SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells
Idha Kurtsdotter et al.
CANCER RESEARCH (2017)
Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway
Haoran Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer
Giandomenico Roviello et al.
CANCER LETTERS (2016)
Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials
Fei Shan et al.
CANCER LETTERS (2016)
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
Jin Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5
Wang Renjie et al.
CANCER LETTERS (2015)
Apatinib for the treatment of gastric cancer
Ruixuan Geng et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer
Xichun Hu et al.
BMC CANCER (2014)
Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype
B. Bhattacharya et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretrnted patients with metastatic triple-negative breast cancer
Xichun Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Overcoming 5-Fu resistance in human non-small cell lung cancer cells by the combination of 5-Fu and cisplatin through the inhibition of glucose metabolism
Jun-gang Zhao et al.
TUMOR BIOLOGY (2014)
Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling
B. N. Prashanth Kumar et al.
BMC CANCER (2013)
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
Sampurna Chatterjee et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial
Jin Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
DNA polymerase ζ as a potential biomarker of chemoradiation resistance and poor prognosis for cervical cancer
Ting-Yan Shi et al.
MEDICAL ONCOLOGY (2013)
Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells
Xiu-zhen Tong et al.
BIOCHEMICAL PHARMACOLOGY (2012)
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo
Shu Tian et al.
CANCER SCIENCE (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters
Yan-jun Mi et al.
CANCER RESEARCH (2010)
Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer
Tomomi Egawa-Takata et al.
CANCER SCIENCE (2010)
Targeting metabolic transformation for cancer therapy
Daniel A. Tennant et al.
NATURE REVIEWS CANCER (2010)
Functional significance of VEGFR-2 on ovarian cancer cells
Whitney A. Spannuth et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence
E. Tchougounova et al.
ONCOGENE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
An Autocrine VEGF/VEGFR2 and p38 Signaling Loop Confers Resistance to 4-Hydroxytamoxifen in MCF-7 Breast Cancer Cells
Reidun Aesoy et al.
MOLECULAR CANCER RESEARCH (2008)
分享论文
